Status:
RECRUITING
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Antisynthetase Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Antisynthetase syndrome (AS) is a rare overlapping myositis characterized by cellular and humoral autoimmune responses directed against aminoacyl-tRNA synthetases. Intesrtitial lung disease (ILD) is a...
Eligibility Criteria
Inclusion
- Patient with new diagnosis of AS with ILD
Exclusion
- Patient with ILD differential diagnosis
- Corticosteroid treatment, immunosuppresive or immunomodulatory drugs in the past 3 months before diagnosis
Key Trial Info
Start Date :
August 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05984394
Start Date
August 26 2024
End Date
October 31 2025
Last Update
August 27 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Bernard Bonnotte
Dijon, France
2
Julien Campagne
Metz, France
3
Paul Decker
Nancy, France
4
Olivier Benveniste
Paris, France